Coronavirus infectious disease 2019 (COVID-19) first reported in Wuhan, China, causes serious respiratory illnesses such as lung failure and pneumonia. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS - CoV-2) the pathogenic agent of COVID-19 has been confirmed as a novel coronavirus. WHO announced COVID-19 a global pandemic and now the whole world is eagerly waiting for vaccines and therapeutic treatment to get rid of this unstoppable coronavirus. As COVID-19 infection, a global threat creates unwanted human casualties and serious economic loss. To stop the ongoing uncontrolled situation researchers are racing to develop prevention and treatment strategies. Vaccines of different countries are in clinical and preclinical trial s and the repurposed-drugs are providing to find out a positive result against COVID-19. The report is an analysis of published information focusing on treatment options including vaccination, drug-therapy, cytokines, therapeutic antibodies. Most of the vaccine ’ s development strategies and drugs target the surface structural spike glycoprotein or S-protein, the major inducer of pathogenic responses. Here, it is reviewed the features of SARS - CoV-2 and the global current status of therapeutic, and vaccine development for the prevention and effective treatment of COVID-19.
KeywordsCOVID-19EpidemiologyTherapeuticVaccineS Protein
Yin, Y. and Wunderink, R. (2017) MERS, SARS and Other Coronaviruses as Causes of Pneumonia. Respirology, 23, 130-137.
Prompetchara, E., Ketloy, C. and Palaga, T. (2020) Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned from SARS and MERS Epidemic. Asian Pacific Journal of Allergy and Immunology, 38, 1-9.
Dhoble, C., Saoji, N., Jeswani, J. and Rios, R. (2015) A 45-Year-Old Undiagnosed Cirrhotic Patient with Hepatopulmonary Syndrome as First Presentation: A Case Report. American Journal of Case Reports, 16, 751-755.
(2020) Pneumonia of Unknown Cause—China. World Health Organization. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/.
(2020) Archived: WHO Timeline—COVID-19. Who.Int. https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19.
(2020) WHO Announces COVID-19 Outbreak a Pandemic. Euro.Who.Int. https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic.
Dhama, K., Sharun, K., Tiwari, R., Dadar, M., Malik, Y., Singh, K. and Chaicumpa, W. (2020) COVID-19, an Emerging Coronavirus Infection: Advances and Prospects in Designing and Developing Vaccines, Immunotherapeutics, and Therapeutics. Human Vaccines & Immunotherapeutics, 16, 1232-1238. https://doi.org/10.1080/21645515.2020.1735227
Tambyah, P. (2016) Zika, MERS, Ebola, SARS and H1N1: Local and Global Responses to Viral Threats. International Journal of Infectious Diseases, 45, 63. https://doi.org/10.1016/j.ijid.2016.02.182
Lu, H. (2020) Drug Treatment Options for the 2019-New Coronavirus (2019-nCOV). BioScience Trends, 14, 69-71. https://doi.org/10.5582/bst.2020.01020
Sheahan, T., Sims, A., Leist, S., Schafer, A., Won, J., Brown, A., Montgomery, S., Hogg, A., Babusis, D., Clarke, M., Spahn, J., Bauer, L., Sellers, S., Porter, D., Feng, J., Cihlar, T., Jordan, R., Denison, M. and Baric, R. (2020) Comparative Therapeutic Efficacy of Remdesivir and Combination Lopinavir, Ritonavir, and Interferon Beta Against MERS-Cov. Nature Communications, 11, Article No 222. https://doi.org/10.1038/s41467-019-13940-6
Wilder-Smith, A. and Freedman, D. (2020) Isolation, Quarantine, Social Distancing and Community Containment: Pivotal Role for Old-Style Public Health Measures in the Novel Coronavirus (2019-nCoV) Outbreak. Journal of Travel Medicine, 27. https://doi.org/10.1093/jtm/taaa020
Kannan, S., Subbaram, K., Ali, S. and Kannan, H. (2020) Molecular Characterization and Amino Acid Homology of Nucleocapsid (N) Protein in SARS-CoV-1, SARS-CoV-2, MERS-CoV, And Bat Coronavirus. Journal of Pure and Applied Microbiology, 14, 757-763. https://doi.org/10.22207/JPAM.14.SPL1.13
(2020) Coronavirus Update (Live): 29,464,002 Cases and 933,121 Deaths from COVID-19 Virus Pandemic—Worldometer. Worldometers.Info. https://www.worldometers.info/coronavirus/.
Parry, J. (2003) WHO Warns That Death Rate from SARS Could Reach 10%. BMJ, 326, 999. https://doi.org/10.1136/bmj.326.7397.999/a
Yao, Z., Zheng, Z., Wu, K. and Junhua, Z. (2020) Immune Environment Modulation in Pneumonia Patients Caused by Coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2. Aging, 12, 7639-7651. https://doi.org/10.18632/aging.103101
Ahn, D., Shin, H., Kim, M., Lee, S., Kim, H., Myoung, J., Kim, B. and Kim, S. (2020) Current Status Of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). Journal of Microbiology and Biotechnology, 30, 313-324. https://doi.org/10.4014/jmb.2003.03011
Xie, M. and Chen, Q. (2020) Insight into 2019 Novel Coronavirus—An Updated Interim Review and Lessons from SARS-CoV and MERS-CoV. International Journal of Infectious Diseases, 94, 119-124. https://doi.org/10.1016/j.ijid.2020.03.071
Andersen, K., Rambaut, A., Lipkin, W., Holmes, E. and Garry, R. (2020) The Proximal Origin of SARS-CoV-2. Nature Medicine, 26, 450-452. https://doi.org/10.1038/s41591-020-0820-9
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., Gao, H., Guo, L., Xie, J., Wang, G., Jiang, R., Gao, Z., Jin, Q., Wang, J. and Cao, B. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X. and Zhang, L. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. The Lancet, 395, 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X. and Peng, Z. (2020) Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323, 1061.
Zhang, J., Dong, X., Cao, Y., Yuan, Y., Yang, Y., Yan, Y., Akdis, C. and Gao, Y. (2020) Clinical Characteristics of 140 Patients Infected with SARS-CoV-2 in Wuhan, China. Allergy, 75, 1730-1741. https://doi.org/10.1111/all.14238
Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., Liu, L., Shan, H., Lei, C., Hui, D., Du, B., Li, L., Zeng, G., Yuen, K., Chen, R., Tang, C., Wang, T., Chen, P., Xiang, J., Li, S., Wang, J., Liang, Z., Peng, Y., Wei, L., Liu, Y., Hu, Y., Peng, P., Wang, J., Liu, J., Chen, Z., Li, G., Zheng, Z., Qiu, S., Luo, J., Ye, C., Zhu, S. and Zhong, N. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, 1708-1720. https://doi.org/10.1056/NEJMoa2002032
de Wit, E., van Doremalen, N., Falzarano, D. and Munster, V. (2016) SARS And MERS: Recent Insights Into Emerging Coronaviruses. Nature Reviews Microbiology, 14, 523-534. https://doi.org/10.1038/nrmicro.2016.81
Memish, Z., Perlman, S., Van Kerkhove, M. and Zumla, A. (2020) Middle East Respiratory Syndrome. The Lancet, 395, 1063-1077. https://doi.org/10.1016/S0140-6736(19)33221-0
Holshue, M., DeBolt, C., Lindquist, S., Lofy, K., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., Diaz, G., Cohn, A., Fox, L., Patel, A., Gerber, S., Kim, L., Tong, S., Lu, X., Lindstrom, S., Pallansch, M., Weldon, W., Biggs, H., Uyeki, T. and Pillai, S. (2020) First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine, 382, 929-936. https://doi.org/10.1056/NEJMoa2001191
Li, Y. and Xia, L. (2020) Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. American Journal of Roentgenology, 214, 1280-1286. https://doi.org/10.2214/AJR.20.22954
(2020) Clinical Management of COVID-19. Who.Int. https://www.who.int/publications/i/item/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
Arakawa, M. and Morita, E. (2019) Flavivirus Replication Organelle Biogenesis in the Endoplasmic Reticulum: Comparison with Other Single-Stranded Positive-Sense RNA Viruses. International Journal of Molecular Sciences, 20, 2336. https://doi.org/10.3390/ijms20092336
Liaw, C., Lim, A., Koh, W., Loh, J., Kan, C., Chan, K., Ting, P., Ng, S., Chew, S., Dua, A., Tan, C., Gao, Q., Ho, H., lee, V. and Tan, B. (2012) Epidemiology of the Four Human Coronaviruses 229E, HKU1, NL63 and OC43 Detected over 30 Months in the Singapore Military. International Journal of Infectious Diseases, 16, e135. https://doi.org/10.1016/j.ijid.2012.05.305
Lvov, D. and Alkhovsky, S. (2020) Source of the COVID-19 Pandemic: Ecology and Genetics of Coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (Subgenus Sarbecovirus), and MERS-CoV (Subgenus Merbecovirus). Problems of Virology, Russian journal, 65, 62-70. https://doi.org/10.36233/0507-4088-2020-65-2-62-70
Satheshkumar, P., Weisberg, A. and Moss, B. (2013) Vaccinia Virus A19 Protein Participates in the Transformation of Spherical Immature Particles to Barrel-Shaped Infectious Virions. Journal of Virology, 87, 10700-10709. https://doi.org/10.1128/JVI.01258-13
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., Zhang, Q. and Wu, J. (2020) Coronavirus Infections and Immune Responses. Journal of Medical Virology, 92, 424-432. https://doi.org/10.1002/jmv.25685
Struck, A., Axmann, M., Pfefferle, S., Drosten, C. and Meyer, B. (2012) A Hexapeptide of the Receptor-Binding Domain of SARS Corona Virus Spike Protein Blocks Viral Entry into Host Cells Via The Human Receptor ACE2. Antiviral Research, 94, 288-296. https://doi.org/10.1016/j.antiviral.2011.12.012
Chenon, M., Camborde, L., Cheminant, S. and Jupin, I. (2011) A Viral Deubiquitylating Enzyme Targets Viral RNA-Dependent RNA Polymerase and Affects Viral Infectivity. The EMBO Journal, 31, 741-753. https://doi.org/10.1038/emboj.2011.424
Moon, S. and Wilusz, J. (2014) Viral Rnas versus the Cellular RNA Decay Machinery. Microbe Magazine, 9, 105-110. https://doi.org/10.1128/microbe.9.105.1
Othman, H., Bouslama, Z., Brandenburg, J., da Rocha, J., Hamdi, Y., Ghedira, K., Srairi-Abid, N. and Hazelhurst, S. (2020) Interaction of the Spike Protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, Hot-Spot Analysis and Effect of the Receptor Polymorphism. Biochemical and Biophysical Research Communications, 527, 702-708. https://doi.org/10.1016/j.bbrc.2020.05.028
Liu, C., Zhou, Q., Li, Y., Garner, L., Watkins, S., Carter, L., Smoot, J., Gregg, A., Daniels, A., Jervey, S. and Albaiu, D. (2020) Research and Development on Therapeutic Agents And Vaccines for COVID-19 and Related Human Coronavirus Diseases. ACS Central Science, 6, 315-331. https://doi.org/10.1021/acscentsci.0c00272
Elshabrawy, H. (2020) SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries. Vaccines, 8, 335. https://doi.org/10.3390/vaccines8020335
Iacobucci, G. (2020) Covid-19: UK Pledges to Reintroduce Contact Tracing to Fight Virus. BMJ, 369, m1591. https://doi.org/10.1136/bmj.m1591
(2020) Modes of Transmission of Virus Causing COVID-19: Implications for IPC Precaution Recommendations. Who.Int. https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations.
Cai, J., Sun, W., Huang, J., Gamber, M., Wu, J. and He, G. (2020) Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020. Emerging Infectious Diseases, 26, 1343-1345. https://doi.org/10.3201/eid2606.200412
Hormati, A., Shahhamzeh, A., Afifian, M., Khodadust, F. and Ahmadpour, S. (2020) Can COVID-19 Present Unusual GI Symptoms? Journal of Microbiology, Immunology and Infection, 53, 384-385. https://doi.org/10.1016/j.jmii.2020.03.020
Lodder, W. and de Roda Husman, A. (2020) SARS-CoV-2 in Wastewater: Potential Health Risk, But Also Data Source. The Lancet Gastroenterology & Hepatology, 5, 533-534. https://doi.org/10.1016/S2468-1253(20)30087-X
Murakami, M., Hata, A., Honda, R. and Watanabe, T. (2020) Letter to the Editor: Wastewater-Based Epidemiology Can Overcome Representativeness and Stigma Issues Related to COVID-19. Environmental Science & Technology, 54, 5311. https://doi.org/10.1021/acs.est.0c02172.
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B. and Jiang, S. (2009) the Spike Protein of SARS-CoV—A Target for Vaccine and Therapeutic Development. Nature Reviews Microbiology, 7, 226-236. https://doi.org/10.1038/nrmicro2090
Poland, G. (2020) Tortoises, Hares, and Vaccines: A Cautionary Note for SARS-CoV-2 Vaccine Development. Vaccine, 38, 4219-4220. https://doi.org/10.1016/j.vaccine.2020.04.073
Alharbi, N., Padron-Regalado, E., Thompson, C., Kupke, A., Wells, D., Sloan, M., Grehan, K., Temperton, N., Lambe, T., Warimwe, G., Becker, S., Hill, A. and Gilbert, S. (2017) Chadox1 And MVA Based Vaccine Candidates Against MERS-CoV Elicit Neutralising Antibodies and Cellular Immune Responses in Mice. Vaccine, 35, 3780-3788. https://doi.org/10.1016/j.vaccine.2017.05.032
(2020) University Of Oxford Commences Clinical Trial for Vaccine Candidate (Chadox1 Ncov-19) Targeting COVID-19. Trial Site News. https://www.trialsitenews.com/university-of-oxford-commences-clinical-trial-for-vaccine-candidate-chadox1-ncov-19-targeting-covid-19-2/.
Zhao, Q. and He, Y. (2020) Challenges of Convalescent Plasma Therapy on COVID-19. Journal of Clinical Virology, 127, 104358. https://doi.org/10.1016/j.jcv.2020.104358
(2020) Draft Landscape of COVID-19 Candidate Vaccines. Who.Int. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
Jiang, X., Rayner, S. and Luo, M. (2020) Does SARS-Cov-2 Has A Longer Incubation Period Than SARS And MERS? Journal of Medical Virology, 92, 476-478.
Uddin, M., Mustafa, F., Rizvi, T., Loney, T., Al Suwaidi, H., Al-Marzouqi, A., Kamal Eldin, A., Alsabeeha, N., Adrian, T., Stefanini, C., Nowotny, N., Alsheikh-Ali, A. and Senok, A. (2020) SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Viruses, 12, 526. https://doi.org/10.3390/v12050526
Zhou, J., Wang, W., Zhong, Q., Hou, W., Yang, Z., Xiao, S., Zhu, R., Tang, Z., Wang, Y., Xian, Q., Tang, H. and Wen, L. (2005) Immunogenicity, Safety, and Protective Efficacy of an Inactivated SARS-Associated Coronavirus Vaccine in Rhesus Monkeys. Vaccine, 23, 3202-3209. https://doi.org/10.1016/j.vaccine.2004.11.075
Stower, H. (2020) Lopinavir–Ritonavir in Severe COVID-19. Nature Medicine, 26, 465. https://doi.org/10.1038/s41591-020-0849-9
Agostini, M., Andres, E., Sims, A., Graham, R., Sheahan, T., Lu, X., Smith, E., Case, J., Feng, J., Jordan, R., Ray, A., Cihlar, T., Siegel, D., Mackman, R., Clarke, M., Baric, R. and Denison, M. (2018) Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio, 9, e00221-18. https://doi.org/10.1128/mBio.00221-18
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., Yuan, Y., Chen, H., Li, H., Huang, H., Tu, S., Gong, F., Liu, Y., Wei, Y., Dong, C., Zhou, F., Gu, X., Xu, J., Liu, Z., Zhang, Y., Li, H., Shang, L., Wang, K., Li, K., Zhou, X., Dong, X., Qu, Z., Lu, S., Hu, X., Ruan, S., Luo, S., Wu, J., Peng, L., Cheng, F., Pan, L., Zou, J., Jia, C., Wang, J., Liu, X., Wang, S., Wu, X., Ge, Q., He, J., Zhan, H., Qiu, F., Guo, L., Huang, C., Jaki, T., Hayden, F., Horby, P., Zhang, D. and Wang, C. (2020) A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine, 382, 1787-1799. https://doi.org/10.1056/NEJMoa2001282
Yanai, H. (2020) Favipiravir: A Possible Pharmaceutical Treatment for COVID-19. Journal of Endocrinology and Metabolism, 10, 33-34. https://doi.org/10.14740/jem645
Ito, K., Ohmagari, N., Mikami, A. and Sugiura, W. (2020) Major Ongoing Clinical Trials for COVID-19 Treatment and Studies Currently Being Conducted or Scheduled in Japan. Global Health & Medicine, 2, 96-101.
Kmietowicz, Z. (2020) Covid-19: Selected NHS Patients Will Be Treated with Remdesivir. BMJ, 369, m2097. https://doi.org/10.1136/bmj.m2097
(2020) 15 Drugs Being Tested to Treat COVID-19 and How They Would Work. Nature.Com. https://www.nature.com/articles/d41591-020-00019-9.
Caly, L., Druce, J., Catton, M., Jans, D. and Wagstaff, K. (2020) The FDA-Approved Drug Ivermectin Inhibits the Replication of SARS-Cov-2 in Vitro. Antiviral Research, 178, 104787. https://doi.org/10.1016/j.antiviral.2020.104787